Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids
Abstract/Contents
- Abstract
- Pancreatic ductal adenocarcinoma (PDAC) is characterized by its fibrotic and stiff extracellular matrix (ECM). However, how the altered cell-ECM signalling contributes to the PDAC tumour phenotype has been difficult to dissect. Here, we design and engineer matrices that recapitulate the key hallmarks of the PDAC tumour ECM to address this knowledge gap. We show that patient-derived PDAC organoids from three patients develop resistance to several clinically-relevant chemotherapies when cultured within high stiffness matrices mechanically matched to in vivo tumours. Using genetic barcoding, we find that while matrix-specific clonal selection occurs, cellular heterogeneity is not the main driver of chemoresistance. Instead, matrix-induced chemoresistance occurs within a stiff environment due to the increased expression of drug efflux transporters mediated by CD44 receptor interactions with hyaluronan. Moreover, PDAC chemoresistance is reversible following transfer from high to low stiffness matrices, suggesting that targeting the fibrotic ECM may sensitize chemoresistant tumours. Overall, our findings support the potential of engineered matrices and patient-derived organoids for elucidating ECM contributions to human disease pathophysiology.
Description
| Type of resource | Dataset, text |
|---|---|
| Date modified | April 11, 2024 |
| Publication date | April 11, 2024 |
Creators/Contributors
| Author | LeSavage, Bauer |
|---|---|
| Author | Zhang, Daiyao |
| Author | Huerta-López, Carla |
| Author | Gilchrist, Aidan |
| Author | Krajina, Brad |
| Author | Karlsson, Kasper |
| Author | Smith, Amber |
| Author | Karagyozova, Kremena |
| Author | Klett, Katarina |
| Author | Huang, Michelle |
| Author | Long, Christopher |
| Author | Kaber, Gernot |
| Author | Madl, Christopher |
| Author | Bollyky, Paul |
| Author | Curtis, Christina |
| Author | Kuo, Calvin |
| Author | Heilshorn, Sarah |
Subjects
| Subject | Pancreatic cancer organoids |
|---|---|
| Subject | Chemoresistance |
| Subject | Extracellular matrix |
| Subject | Engineered matrices |
| Subject | CD44 |
| Genre | Data |
| Genre | Tabular data |
| Genre | Data sets |
| Genre | Dataset |
| Genre | Tables (data) |
Bibliographic information
Access conditions
- Use and reproduction
- User agrees that, where applicable, content will not be used to identify or to otherwise infringe the privacy or confidentiality rights of individuals. Content distributed via the Stanford Digital Repository may be subject to additional license and use restrictions applied by the depositor.
- License
- This work is licensed under a Creative Commons Attribution 4.0 International license (CC BY).
Preferred citation
- Preferred citation
- LeSavage, B., Zhang, D., Huerta-López, C., Gilchrist, A., Krajina, B., Karlsson, K., Smith, A., Karagyozova, K., Klett, K., Huang, M., Long, C., Kaber, G., Madl, C., Bollyky, P., Curtis, C., Kuo, C., and Heilshorn, S. (2024). Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids . Stanford Digital Repository. Available at https://purl.stanford.edu/nw595bg6402. https://doi.org/10.25740/nw595bg6402.
Collection
Stanford Research Data
View other items in this collection in SearchWorksContact information
- Contact
- heilshorn@stanford.edu
Also listed in
Loading usage metrics...